Global epidemiology of Barrett's esophagus

Expert Review of Gastroenterology and Hepatology

Volumn 5, Issue 1, 2011, Pages 123-130

  Fock, Kwong Ming ^a   Ang, Tiing Leong ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Barrett's esophagus; endoscopy; epidemiology; esophageal adenocarcinoma; surveillance

Indexed keywords

AFRICA; ASIA; AUSTRALIA; BARRETT ESOPHAGUS; CANCER RISK; CHROMOENDOSCOPY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SURVEILLANCE; EARLY DIAGNOSIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; EUROPE; GASTROESOPHAGEAL REFLUX; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; MIDDLE EAST; NARROW BAND IMAGING; NORTH AMERICA; PREDICTION; REVIEW; RISK ASSESSMENT; SOUTH AMERICA;

BARRETT ESOPHAGUS; DISEASE PROGRESSION; ENDOSCOPY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; PREVALENCE; RISK FACTORS; WORLD HEALTH;

EID: 79951612406     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.10.82     Document Type: Review

References (70)

1. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 127, 310-330 (2004). (Pubitemid 38962298)
2. Wang KK, Sampliner RE; the Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J Gastroenterol. 103, 788-797 (2008). (Pubitemid 351406009)
3. Shaheen NJ, Richter JE. Barrett's esophagus. Lancet 373, 850-861 (2009).
4. Wu JCY. Gastroesophageal reflux disease: an Asian perspective. J. Gastroenterol. Hepatol. 23, 1785-1793 (2008).
5. Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systemic review and meta-analysis. Am. J. Epidemiol. 168, 237-249 (2008). (Pubitemid 352019777)
6. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 99, 918-922 (1990). (Pubitemid 20338445)
7. Conio M, Cameron AJ, Romero Y et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 48, 304-309 (2001). (Pubitemid 32269555)
8. Musana AK, Resnick JM, Torbey CF, Mukesh BN, Greenlee RT. Barrett's esophagus: incidence and prevalence estimates in a rural Mid-Western population. Am. J. Gastroenterol. 103, 516-524 (2008). (Pubitemid 351405967)
9. Rex DK, Cummings OW, Shaw M et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125, 1670-1677 (2003). (Pubitemid 37500431)
10. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 123, 461-467 (2002). (Pubitemid 34827190)
11. Ward EM, Wolfsen HC, Achem SR et al. Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am. J. Gastroenterol. 101, 12-17 (2006). (Pubitemid 43381703)
12. Westhoff B, Brotze S, Weston A et al. The frequency of Barrett's esophagus in high-risk patients with chronic GERD. Gastrointest. Endosc. 61, 226-231 (2005). (Pubitemid 40261070)
13. Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis. Esophagus 23(6), 451-457 (2010).
14. Corley DA, Kubo A, Levin TR et al. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut 58, 182-188 (2009).
15. Lam KD, Phan JT, Garcia RT et al. Low proportion of Barrett's esophagus in Asian Americans. Am. J. Gastroenterol. 103, 1625-1630 (2008).
16. Veldhuyzen van Zanten SJ, Thomson AB et al. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy. Aliment. Pharmacol. Ther. 23, 595-599 (2006).
17. Freitas MC, Moretzsohn LD, Coelho LG. Prevalence of Barrett's esophagus in individuals without typical symptoms of gastroesophageal reflux disease. Arq. Gastroenterol. 45, 46-49 (2008). (Pubitemid 351600609)
18. Andreollo NA, Michelino MU, Brandalise NA, Lopes LR, Trevisan MA, Leonardi LS. [Incidence and epidemiology of Barrett's epithelium at the Gastrocentro- UNICAMP]. Arq. Gastroenterol. 34, 22-26 (1997). (Pubitemid 127453822)
19. Ronkainen J, Aro P, Storskrubb T et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129, 1825-1831 (2005). (Pubitemid 41772961)
20. Zagari RM, Fuccio L, Wallander MA et al. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 57, 1354-1359 (2008).
21. Playford RJ. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut 55, 442 (2006).
22. Alcedo J, Ferr?ndez A, Arenas J et al. Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance. Dis. Esophagus 22, 239-248 (2009).
23. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett's oesophagus in the general population. Gut 54, 1062-1066 (2005). (Pubitemid 41025895)
24. Odemis B, Ci?ek B, Zengin NI et al. Barrett's esophagus and endoscopically assessed esophagogastric junction integrity in 1000 consecutive Turkish patients undergoing endoscopy: a prospective study. Dis. Esophagus 22, 649-655 (2009).
25. Kendall BJ, Whiteman DC. Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region. Am. J. Gastroenterol. 102, 204-205 (2007).
26. Chen X, Zhu LR, Hou XH. The characteristics of Barrett's esophagus: an analysis of 4120 cases in China. Dis. Esophagus. 22, 348-353 (2009).
27. Tseng PH, Lee YC, Chiu HM et al. Prevalence and clinical characteristics of Barrett's esophagus in a Chinese general population. J. Clin. Gastroenterol. 42, 1074-1079 (2008).
28. Hongo M. Review article: Barrett's oesophagus and carcinoma in Japan. Aliment. Pharmacol. Ther. 20 (Suppl. 8), 50-54 (2004). (Pubitemid 39657668)
29. Park JJ, Kim JW, Kim HJ et al. The prevalence of and risk factors for Barrett's esophagus in a Korean population: a nationwide multicenter prospective study. J. Clin. Gastroenterol. 43, 907-914 (2009).
30. Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan J. A comparison of the clinical, demographic and psychiatric profiles among patients with erosive and non-erosive reflux disease in a multi-ethnic Asian country. World J. Gastroenterol. 11, 3558-3561 (2005). (Pubitemid 40903512)
31. Rajendra S, Kutty K, Karim N. Ethnic differences in the prevalence of endoscopic esophagitis and Barrett's esophagus: the long and short of it all. Dig. Dis. Sci. 49, 237-242 (2004). (Pubitemid 38392223)
32. Rajendra S, Ackroyd R, Murad S et al. Human leucocyte antigen determinants of susceptibility to Barrett's oesophagus in Asians - a preliminary study. Aliment. Pharmacol. Ther. 21, 1377-1383 (2005). (Pubitemid 40813684)
33. Segal I. The gastro-oesophageal reflux disease complex in sub-Saharan Africa. Eur. J. Cancer Prev. 10, 209-212 (2001). (Pubitemid 32530364)
34. Fouad YM, Makhlouf MM, Tawfik HM, el-Amin H, Ghany WA, el-Khayat HR. Barrett's esophagus: prevalence and risk factors in patients with chronic GERD in Upper Egypt. World J. Gastroenterol. 15, 3511-3515 (2009).
35. Ahmed HH, Mudawi HM, Fedail SS. Gastro-oesophageal reflux disease in Sudan: a clinical endoscopic and histopathological study. Trop. Gastroenterol. 25, 135-138 (2004).
36. Gadour MO, Ayoola EA. Barrett's oesophagus and oesophageal cancer in Saudi Arabia. Trop. Gastroenterol. 20, 111-115 (1999).
37. Seidel D, Muangpaisan W, Hiro H, Mathew A, Lyratzopoulos G. The association between body mass index and Barrett's esophagus: a systematic review. Dis. Esophagus 22, 564-570 (2009).
38. Corley DA, Kubo A, Levin TR et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 133, 34-41 (2007). (Pubitemid 47031134)
39. Kubo A, Levin TR, Block G et al. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control 20, 303-311 (2009).
40. Smith KJ, O'Brien SM, Green AC, Webb PM, Whiteman DC. Current and past smoking significantly increase risk for Barrett's esophagus. Clin. Gastroenterol. Hepatol. 7, 840-848 (2009).
41. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J. Gastroenterol. Hepatol. 24, 729-735 (2009).
42. Sharma P, Wani S, Romero Y, Johnson D, Hamilton F. Racial and geographic issues in gastroesophageal reflux disease. Am. J. Gastroenterol. 103, 2669-2680 (2008).
43. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am. J. Gastroenterol. 100, 1923-1928 (2005).
44. Rajendra S, Ackroyd R, Robertson IK, Ho JJ, Karim N, Kutty KM. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East. Helicobacter 12, 177-183 (2007).
45. O'Connor HJ. Helicobacter pylori and gastroaoesophageal reflux disease - clinical implications and management. Aliment. Pharmacol. Ther. 13, 117-127 (1999).
46. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. Br. Med. J. 326, 737 (2003).
47. Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 131, 1392-1399 (2006). (Pubitemid 44708937)
48. Chang CY, Lee YC, Lee CT et al. The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population. Am. J. Gastroenterol. 104, 13-20 (2009).
49. Akiyama T, Inamori M, Akimoto K et al. Risk factors for the progression of endoscopic Barrett's epithelium in Japan: a multivariate analysis based on the Prague C & M Criteria. Dig. Dis. Sci. 54, 1702-1707 (2009).
50. Hirota WK, Zuckerman MJ, Adler DG et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest. Endosc. 63, 570-580 (2006).
51. Fock KM, Talley NJ, Fass R et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J. Gastroenterol. Hepatol. 23, 8-22 (2008). (Pubitemid 350265214)
52. Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 122, 633-640 (2002). (Pubitemid 34173814)
53. El-Serag HB, Aguirre TV, Davis S et al. Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am. J. Gastroenterol. 99, 1877-1883 (2004). (Pubitemid 39421227)
54. Hillman LC, Chiragakis L, Shadbolt B et al. Proton pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus. Med. J. Aust. 180, 387-391 (2004). (Pubitemid 38528957)
55. Ouatu-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology 117, 327-335 (1999). (Pubitemid 29352940)
56. Hofstetter WL, Peters JH, DeMeester T et al. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann. Surg. 234, 532-539 (2001). (Pubitemid 32946715)
57. Csendes A, Burdiles P, Braghetto I et al. Adenocarcinoma appearing very late after antireflux surgery for Barrett's esophagus: long term follow up, review of the literature, and addition of six patients. J. Gastrointest. Surg. 8, 434-441 (2004). (Pubitemid 38561207)
58. Streitz JM, Andrews CW, Ellis FH. Endoscopic surveillance of Barrett's esophagus: does it help? J. Thorac. Cardiovasc. Surg. 105, 383-388 (1993).
59. Conio M, Blanchi S, Lapertosa G et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am. J. Gastroenterol. 98, 1931-1939 (2003). (Pubitemid 37185786)
60. Streitz JM, Jr., Ellis FH Jr, Tilden RL, Erickson RV. Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. Am. J. Gastroenterol. 93, 911-915 (1998). (Pubitemid 29076975)
61. Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am. J. Gastroenterol. 94, 2043-2053 (1999). (Pubitemid 29374530)
62. Falk GW, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest. Endosc. 49, 170-176 (1999). (Pubitemid 29111309)
63. Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and non-surveyed patients. J. Thorac. Cardiovasc. Surg. 108, 813-821 (1994).
64. Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am. J. Gastroenterol. 95, 3089-3096 (2000).
65. Shahid MW, Wallace MB. Endoscopic imaging for the detection of esophageal dysplasia and carcinoma. Gastrointest. Endosc. Clin. N. Am. 20, 11-24 (2010).
66. Fock KM, Teo EK, Chan YH et al. The utility of narrow band imaging (NBI) endoscopy in the detection of goblet metaplasia in patients with gastroesophageal reflux disease (GERD). Gastrointest. Endosc. 63, AB109 (2006).
67. Wolfsen HC, Crook JE, Krishna M et al. Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus. Gastroenterology 135, 24-31 (2008). (Pubitemid 351899007)
68. Sharma P, Bansal A, Mathur S et al. The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus. Gastrointest. Endosc. 64, 167-175 (2006). (Pubitemid 44081900)
69. Kara MA, Peters FP, Fockens P, ten Kate FJ, Bergman JJ. Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. Gastrointest. Endosc. 64, 176-185 (2006). (Pubitemid 44062483)
70. Curvers WL, Singh R, Song LM et al. Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system. Gut 57, 167-172 (2008). (Pubitemid 351158041)